Company Filing History:
1 out of 8,373 
1 out of 3,539 
Years Active: 2020
Title: Helena De Puig: Innovator in Dengue Virus Detection
Introduction
Helena De Puig is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of biomedical research, particularly in the detection of dengue virus serotypes. Her innovative work has the potential to improve diagnostic methods and therapeutic approaches for dengue virus infections.
Latest Patents
Helena De Puig holds a patent for "Anti-dengue virus NS1 protein monoclonal antibodies." This invention provides matched antibody pairs for the specific detection of one or more of the four dengue virus serotypes in a biological sample. Each matched antibody pair is capable of detecting not more than one serotype of dengue virus NS1 protein that may be present in the sample. The invention facilitates the development of confirmatory in vitro diagnostic tests, such as sandwich immunoassays, that can detect and distinguish the presence of dengue virus serotypes in biological samples, preferably those derived from human subjects. Additionally, the invention includes kits comprising the matched antibody pairs and methods for using these kits for immunoassays. It also provides monoclonal antibodies specific for the NS1 protein of dengue virus and therapeutic compositions for treating dengue virus infection. Helena has 1 patent to her name.
Career Highlights
Throughout her career, Helena De Puig has worked with prestigious institutions, including the Massachusetts Institute of Technology and the National Institutes of Health, a component of the US Department of Health & Human Services. Her work in these organizations has allowed her to contribute to significant advancements in medical research and diagnostics.
Collaborations
Helena has collaborated with notable colleagues, including Irene Bosch and Kimberly Hamad-Schifferli. These partnerships have further enhanced her research and innovation in the field of dengue virus detection.
Conclusion
Helena De Puig is a trailblazer in the field of biomedical research, particularly in the detection and treatment of dengue virus infections. Her innovative patent and collaborations with esteemed institutions and colleagues highlight her commitment to advancing medical science.